Covered recipient · General Payments record
OTTO L SECADA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,753.51
- Reported across 182 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $368.28 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $183.03 | 5 |
| Novo Nordisk AS | $67.33 | 3 |
| Amgen Inc. | $47.42 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.00 | 1 |
| GlaxoSmithKline, LLC. | $24.07 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.00 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116100157 | CMS |
| Amgen Inc. | $18.57 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117679179 | CMS |
| Amgen Inc. | $13.85 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116100165 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118243916 | CMS |
| GlaxoSmithKline, LLC. | $24.07 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116321579 | CMS |
| Lilly USA, LLC | $18.13 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135313774 | CMS |
| Lilly USA, LLC | $117.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135313778 | CMS |
| Lilly USA, LLC | $15.50 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135261880 | CMS |
| Lilly USA, LLC | $16.50 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135303755 | CMS |
| Lilly USA, LLC | $15.90 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135302567 | CMS |
| Novo Nordisk Inc | $22.86 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096584743 | CMS |
| Novo Nordisk Inc | $23.33 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097194553 | CMS |
| Novo Nordisk Inc | $21.14 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097298406 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.43 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153470491 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.